Key facts
- This page summarizes Shane Barton's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jun 2023, 16:20.
Shane Barton - 07 Jun 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- VP & Corporate Controller
- Issuer ticker
- DTIL
- Reported as of
- 07 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2023, 16:20:59 UTC
- Prior SEC filing
- 07 Mar 2023
- Next SEC filing
- 25 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Alexander Kelly, Attorney-in-Fact for Shane Barton
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shane Barton filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 09 Jun 2023.
Change
- Previous filing in this sequence was filed on 07 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,060
- Change %
- +28%
- Price
- Shares after
- 27,502
- Date
- 07 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,060
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 6,060
- Date
- 07 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,060
- Exercise price
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
Footnote F3
Amount includes 20 shares that were inadvertently omitted from the Form 4 filed on March 7, 2023 by the Reporting Person.
Footnote F4
On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.